84 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
2142
HBM Holdings
HK$4.589.8%177.6%HK$3.3bn/aPE20.1xn/an/a
6998
Genor Biopharma Holdings
HK$1.72-4.4%91.1%HK$888.5mn/aPS57.3xn/an/a
6622
Zhaoke Ophthalmology
HK$1.8635.8%9.4%HK$1.0bHK$2.50PS16.6xE11.7%n/a
2161
JBM (Healthcare)
HK$1.75-2.2%82.3%HK$1.4bn/aPE8.7xn/a6.3%
1530
3SBio
HK$6.48-0.2%17.8%HK$15.3bHK$8.40PE8.6xE16.2%3.7%
570
China Traditional Chinese Medicine Holdings
HK$2.000%-41.7%HK$10.1bHK$1.70PE10.2xS-1.4%n/a
1558
YiChang HEC ChangJiang Pharmaceutical
HK$9.662.0%9.9%HK$8.5bHK$12.59PE4.8xS-1.2%0%
1681
Consun Pharmaceutical Group
HK$8.372.1%57.9%HK$7.0bHK$10.20PE7.8xE14.7%6.9%
1061
Essex Bio-Technology
HK$2.754.2%17.5%HK$1.6bHK$5.12PE5.9xE6.2%4.4%
719
Shandong Xinhua Pharmaceutical
HK$5.80-0.7%7.4%HK$9.3bn/aPE8.3xn/a0.9%
1643
Modern Chinese Medicine Group
HK$0.4110.8%24.2%HK$246.0mn/aPE16xn/a0%
2137
Brii Biosciences
HK$1.14-5.0%-34.9%HK$828.8mHK$1.00PS20.2xE-7.4%n/a
897
Wai Yuen Tong Medicine Holdings
HK$0.3820.6%-8.4%HK$427.5mn/aPE206.3xn/a7.9%
1167
Jacobio Pharmaceuticals Group
HK$1.50-9.1%-39.5%HK$1.2bHK$1.85PS47.6xS-2.6%n/a
1312
Kontafarma China Holdings
HK$0.03-11.8%-11.8%HK$167.7mn/aPS0.2xn/a0%
1672
Ascletis Pharma
HK$4.280.9%131.4%HK$4.1bHK$3.94PS381.3xE20.1%n/a
6996
Antengene
HK$1.3161.7%12.0%HK$890.1mHK$1.33PS14.8xE16.8%n/a
8225
China Health Group
HK$0.17-11.5%14.9%HK$169.2mn/aPS6.4xn/an/a
2511
HighTide Therapeutics
HK$1.253.3%-89.6%HK$643.5mn/aPB1.1xn/an/a
2348
Dawnrays Pharmaceutical (Holdings)
HK$1.180.9%0.9%HK$1.8bn/aPE2.9xn/a6.5%
2633
Jacobson Pharma
HK$1.25-6.0%104.9%HK$2.5bn/aPE9.8xn/a5.6%
1349
Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd
HK$2.617.4%14.5%HK$7.2bn/aPE24xn/a1.6%
239
Pak Fah Yeow International
HK$2.45-2.4%33.9%HK$763.5mn/aPE7.9xn/a8.8%
867
China Medical System Holdings
HK$7.783.0%-34.2%HK$18.8bHK$11.00PE12.6xE21.4%5.4%
Page 1 of 4